Samsung Biologics has secured a 97.98% stake in the bid for Polypeptide Group, a global peptide cons..

From the source

Samsung Biologics has secured a 97.98% stake in the bid for Polypeptide Group, a global peptide cons..

Samsung Biologics has secured a 97.98% stake in the bid for Polypeptide Group, a global peptide consignment development and production (CDMO) company. As it has met the requirements for compulsory purchase of remaining shares of minority shareholders, it plans to secure 100% of its shares.